Since 2012, the biotechnology sector has received the most investment with 1.85Bn$ across 126 transactions, accounting for 18% of total venture capital investment. Although investments in companies related to... are currently gaining momentum,.
One of the main barriers to the growth of Spanish biotech companies is their small size (over 95% have fewer than 250 employees), which prevents them from accelerating their entry into foreign markets, for example. The main cause of this small size is due to...
On the 6th of June, the Government of Spain published the plan of measures for growth, competitiveness and efficiency. This announcement was published in the same week that the Government announced future reductions in taxes on both Corporate Income and...
Crowdfunding has grown a lot in recent years; according to a study by the agency Massolution, in 2012 this type of financing grew by 81% compared to the previous year, reaching a total of $2,700M worldwide, and in 2013 the figure...
The limitation on the investment amount, the main fear of all platforms regarding the first draft of the preliminary Bill, has been overcome. Although the preliminary Bill states that by default all investors will have a limit on their investments (maximum 3,000...
